1. Главная
  2. Ресурсы
  3. Библиотечный поиск
International MyelomaWorking GroupRecommendations forthe Treatment ofMultipleMyeloma–Related BoneDisease Evangelos TerposGareth J. MorganMeletios Α. Dimopoulos2013 год

International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease
статья из журнала

Полный текстСтраница публикацииПубликация в OpenAlex
Аннотация: The aim of the International Myeloma Working Group was to develop practice recommendations for the management of multiple myeloma (MM) -related bone disease.An interdisciplinary panel of clinical experts on MM and myeloma bone disease developed recommendations based on published data through August 2012. Expert consensus was used to propose additional recommendations in situations where there were insufficient published data. Levels of evidence and grades of recommendations were assigned and approved by panel members.Bisphosphonates (BPs) should be considered in all patients with MM receiving first-line antimyeloma therapy, regardless of presence of osteolytic bone lesions on conventional radiography. However, it is unknown if BPs offer any advantage in patients with no bone disease assessed by magnetic resonance imaging or positron emission tomography/computed tomography. Intravenous (IV) zoledronic acid (ZOL) or pamidronate (PAM) is recommended for preventing skeletal-related events in patients with MM. ZOL is preferred over oral clodronate in newly diagnosed patients with MM because of its potential antimyeloma effects and survival benefits. BPs should be administered every 3 to 4 weeks IV during initial therapy. ZOL or PAM should be continued in patients with active disease and should be resumed after disease relapse, if discontinued in patients achieving complete or very good partial response. BPs are well tolerated, but preventive strategies must be instituted to avoid renal toxicity or osteonecrosis of the jaw. Kyphoplasty should be considered for symptomatic vertebral compression fractures. Low-dose radiation therapy can be used for palliation of uncontrolled pain, impending pathologic fracture, or spinal cord compression. Orthopedic consultation should be sought for long-bone fractures, spinal cord compression, and vertebral column instability.
Год издания: 2013
Авторы: Evangelos Terpos, Gareth J. Morgan, Meletios Α. Dimopoulos, Matthew T. Drake, Suzanne Lentzsch, Noopur Raje, Orhan Sezer, Ramón García‐Sánz, Kazuyuki Shimizu, Ingemar Turesson, Tony Reiman, Artur Jurczyszyn, Giampaolo Merlini, Andrew Spencer, Xavier Leleu, Michèle Cavo, Nikhil C. Munshi, S. Vincent Rajkumar, Brian G.M. Durie, G. David Roodman
Издательство: Lippincott Williams & Wilkins
Источник: Journal of Clinical Oncology
Ключевые слова: Bone health and treatments, Multiple Myeloma Research and Treatments, Radiopharmaceutical Chemistry and Applications
Другие ссылки: Journal of Clinical Oncology (PDF)
Journal of Clinical Oncology (HTML)
Monash University Research Portal (Monash University) (HTML)
IUScholarWorks (Indiana University) (PDF)
IUScholarWorks (Indiana University) (HTML)
Gredos (University of Salamanca) (PDF)
Gredos (University of Salamanca) (HTML)
Europe PMC (PubMed Central) (PDF)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
PubMed (HTML)